This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Webinar to cover FDA oversight of hemp-derived products
Speakers include FDA policy advisor, food safety consultant.
An upcoming webinar will cover the U.S. Food and Drug Administration’s role in oversight of hemp-derived cannabis products and food safety concerns associated with producing them.
The passage of the 2018 Farm Bill has fueled competitive innovation of cannabis products derived from hemp among food and beverage manufacturers. This webinar, set for Aug. 8 at 2 p.m. EST, will feature an overview of FDA’s role in regulating these products, FDA’s activities in this area, and regulatory and food safety challenges surrounding these products.